Cargando…
Breast Cancer Risk in Relation to the Interval Between Menopause and Starting Hormone Therapy
BACKGROUND: Although breast cancer risk is greater in users of estrogen–progestin than estrogen-only formulations of menopausal hormonal therapy, reports on their effects have been somewhat inconsistent. We investigated whether the timing of these therapies affected breast cancer incidence. METHODS:...
| Autores principales: | , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2011
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3039726/ https://www.ncbi.nlm.nih.gov/pubmed/21278356 http://dx.doi.org/10.1093/jnci/djq527 |